Why Ocugen Stock Couldn't Outrun the Market Today
Published on: Wednesday 12 January 2022
The coronavirus vaccine that it has licensed does very well against variants like omicron, but it's still a laggard.
News source: https://www.msn.com/en-us/money/topstocks/why-ocugen-stock-couldnt-outrun-the-market-today/ar-AASIpXh
